SCHEMBL6712909

SCHEMBL6712909

O=C1C2=CC=CC(=O)C2Sc2ccccc21

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTK P33981 1/20 0.33
MAPK8 P45983 1/20 0.33
MAPK9 P45984 1/20 0.33
MAPK10 P53779 1/20 0.33
MAPT P10636 5/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
SLC2A1 P11166 1/20 0.32
KDM4E B2RXH2 2/20 0.31
ALDH1A1 P00352 2/20 0.31
HSD17B10 Q99714 2/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
TSHR P16473 2/20 0.31
MAPK1 P28482 2/20 0.31
TP53 P04637 1/20 0.31
ALOX15 P16050 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
CDC25B P30305 1/20 0.30
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7905020 0.90 MAPT (0.31) MAPTSMN1; SMN2SLC2A1TSHRMAPK1
SCHEMBL14230550 0.71 TTK (0.33) TTKMAPK8MAPK9MAPK10MAPT
SCHEMBL13246456 0.69 TTK (0.38) TTKMAPK8MAPK9MAPK10MAPT
SCHEMBL3274379 0.68 MAPT (0.42) TTKMAPK8MAPK9MAPK10MAPT
SCHEMBL5969253 0.67 MAPT (0.41) TTKMAPK8MAPK9MAPK10MAPT
SCHEMBL6049871 0.65 CYP19A1 (0.38) TTKMAPK8MAPK9MAPK10MAPT
SCHEMBL6688204 0.63 MAPT (0.45) MAPK10MAPTSMN1; SMN2KDM4EALDH1A1
SCHEMBL2458269 0.63 MAPK10 (0.41) TTKMAPK8MAPK9MAPK10MAPT
SCHEMBL2233981 0.61 TSHR (0.37) TTKMAPK8MAPK9MAPK10SMN1; SMN2
SCHEMBL4324158 0.61 TTK (0.35) TTKMAPK8MAPK9MAPK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040242901-A1 Sulfoniun salts, methods for their preparation and use thereof as phtoinitiators for radiation curable systems LAMBERTI SPA (IT) 2004-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040242901-A1 Sulfoniun salts, methods for their preparation and use thereof as phtoinitiators for radiation curable systems ARSA, TST, STS TTK 3999/4885MAPK8 3296/4885MAPK9 1506/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.